The Canadian province of British Columbia is restoring funding for the Therapeutics Initiative, an independent drug evaluation body endorsing medications that should be included in the drug plan PharmaCare. "It means stronger patient protection through evidence-based evaluations of new drugs," the University of British Columbia's Gavin Stuart said. "It is critical for our researchers to have access to health care data."

Full Story:
PharmaTimes (U.K.)

Related Summaries